Beruflich Dokumente
Kultur Dokumente
REVISION—February 2016
7. Communicability: As long as patient sheds b. History of typhoid fever, with date and
typhoid bacilli. place of residence at time diagnosed.
c. History of typhoid fever in family, tive. Releases may be given 3-12 months
relatives, friends and neighbors, with after onset.
place of residence and time of illness.
b. If unable to obtain release 1 year after
d. Name and address of case(s) traced to onset, report and follow as chronic
carrier. Identify probable method and time carrier.
of transmission.
c. Specimens must be submitted to the
e. Place of birth of carrier, reason for Public Health Laboratory.
obtaining first positive culture.
3. CHRONIC CARRIERS:
CONTROL OF CASE, CONTACTS &
CARRIERS a. Visit at least twice yearly and offer to
repeat cultures every 6 months.
Public Health Nursing Protocol: Repeating cultures is voluntary. If
Home visit is required – a face to face interview surveillance specimen is negative,
is required. proceed with attempt to clear. Verify
address and adherence to “Carrier
Refer to “Public Health Nursing Home Visit Agreement.”
REQUIRED Algorithm” (B-73 Part IV Public
Health Nursing Home Visit Protocol). b. Release: Request release from State
Department of Health Services through
For definition of sensitive occupation or situation ACDC when:
(SOS), see B-73, Part I, Section 12. Individuals
living in a group setting, including a skilled Fecal or gallbladder carrier: 6
nursing or intermediate care facility, are consecutive negative feces and urine
considered to be in a sensitive situation. specimens submitted at 1-month or
greater intervals beginning at least 7
Carriers cannot be released from supervision days after completion of therapy.
until cleared according to public health law.
Urinary or kidney carrier: 6
Prior written approval from the Area Medical consecutive negative urine specimens
Director after consultation with ACDC is required submitted at 1-month or greater
before any admission to a skilled nursing or intervals beginning at least 7 days after
intermediate care facility (B-73, Part II, Section completion of therapy.
2A).
NOTE: All specimens must be submitted to
1. RESTRICTIONS FOR ALL CARRIERS: the Public Health Laboratory.
PREVENTION-EDUCATION